COSMO PHARMACEUTICALS N.V. EUR0.26 (REGD) financial statements, including revenue, expenses, and profit
The total revenue of 0RGI for the last semiannual is 123.22 M CHF, and it's 5.94% lower compared to the previous semiannual. The net income of H2 24 is 53.92 M CHF.